2011
DOI: 10.1111/j.1601-0825.2011.01792.x
|View full text |Cite
|
Sign up to set email alerts
|

Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review

Abstract: OBJECTIVES: Human papillomavirus (HPV) in oral carcinoma (OSCC) and potentially malignant disorders (OPMD) is controversial. The primary aim was to calculate pooled risk estimates for the association of HPV with OSCC and OPMD when compared with healthy oral mucosa as controls. We also examined the effects of sampling techniques on HPV detection rates. METHODS: Systematic review was performed using PubMed (January 1966-September 2010 and EMBASE (January 1990-September 2010. Eligible studies included randomized … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

10
308
3
11

Year Published

2012
2012
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 303 publications
(332 citation statements)
references
References 80 publications
10
308
3
11
Order By: Relevance
“…The primary antibody for p16 was a mouse monoclonal antibody clone E6H4TM directed against human P16INK4a and a standard twostep immunohistochemical staining procedure was used for formalin-fixed, paraffin-embedded tissue using horseradish peroxidase and goat anti-mouse antibody (CINtecTM Histology Kit, MTM Laboratories, Westborough, MA, USA). In situ hybridization studies were performed using a cocktail of biotinylated probes against low-risk HPV genotypes 6 and 11 and high-risk HPV genotypes 16,18,31,33,35,39,45, 51, 52, 56, 58, and 66 on the Ventana Benchmark XT automated platform (Ventana Medical Systems, Tucson, AZ, USA).…”
Section: Methodsmentioning
confidence: 99%
“…The primary antibody for p16 was a mouse monoclonal antibody clone E6H4TM directed against human P16INK4a and a standard twostep immunohistochemical staining procedure was used for formalin-fixed, paraffin-embedded tissue using horseradish peroxidase and goat anti-mouse antibody (CINtecTM Histology Kit, MTM Laboratories, Westborough, MA, USA). In situ hybridization studies were performed using a cocktail of biotinylated probes against low-risk HPV genotypes 6 and 11 and high-risk HPV genotypes 16,18,31,33,35,39,45, 51, 52, 56, 58, and 66 on the Ventana Benchmark XT automated platform (Ventana Medical Systems, Tucson, AZ, USA).…”
Section: Methodsmentioning
confidence: 99%
“…Seven years later, in 1983, we published the first evidence suggesting that a subgroup (some 20 %) of oral cancers is associated with HPV, based on detection of HPV structural proteins in these lesions using an antibody prepared against pooled HPV types [39]. We subsequently identified HPV types 11, 16 and 18 in these samples [40][41][42][43][44][45][46][47][48][49]. This concept has now been well accepted, and a growing body of evidence is supporting that approximately 20 % of oral cancers and 60-80 % of oropharyngeal cancers are caused by HPV [41][42][43][44].…”
Section: Hpv and Head And Neck Cancer (Hnscc)mentioning
confidence: 99%
“…We subsequently identified HPV types 11, 16 and 18 in these samples [40][41][42][43][44][45][46][47][48][49]. This concept has now been well accepted, and a growing body of evidence is supporting that approximately 20 % of oral cancers and 60-80 % of oropharyngeal cancers are caused by HPV [41][42][43][44]. In 2011, the International Agency of Research of Cancer (IARC), classifying both chemical and biological carcinogens to humans, declared that there is sufficient evidence that HPV-16 is causally associated with oral cancer [45].…”
Section: Hpv and Head And Neck Cancer (Hnscc)mentioning
confidence: 99%
“…Despite these limitations, a recent meta-analysis by Syrjanen et al [19] did find an increased risk of HPV detection in oral cavity potential premalignant lesions and dysplasia relative to controls in biopsies (odds ratio of 3.87, 95 % CI 2.22-6.13 and 5.10, 95 % CI 2.03-12.80, respectively). Another meta-analysis including 15 studies of oral cavity dysplastic lesions found an HPV prevalence of 25.3 % [18].…”
Section: Discussionmentioning
confidence: 98%
“…For these reasons, some consider all HPV-related neoplasia of the tonsillar crypts as potentially malignant regardless of whether or not there is clear-cut histologic evidence of stromal invasion [17]. Numerous studies have also evaluated squamous dysplasia/carcinoma in situ of the surface mucosa of the upper aerodigestive tract (mainly oral cavity but also larynx) for the presence of HPV [18][19][20][21][22][23][24][25]. However, the rates of HPV detection are widely variable between studies.…”
Section: Discussionmentioning
confidence: 99%